AFTATE BACITRACIN ZINC- bacitracin zinc ointment 
Sabel Med LLC

Disclaimer: Most OTC drugs are not reviewed and approved by FDA, however they may be marketed if they comply with applicable regulations and policies. FDA has not evaluated whether this product complies.

----------

Bacitracin Zinc Ointment 1 oz (28g) tube
Bacitracin Zinc Ointment 0.5 oz (14g) tube

Warnings section

warning section

inactives

purpose

Keep out of reach

active ingredient

dosage

Uses

tube-principle display

AFTATE BACITRACIN ZINC 
bacitracin zinc ointment
Product Information
Product TypeHUMAN OTC DRUGItem Code (Source)NDC:70356-125
Route of AdministrationTOPICAL
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
BACITRACIN ZINC (UNII: 89Y4M234ES) (BACITRACIN - UNII:58H6RWO52I) BACITRACIN500 [iU]  in 1 g
Inactive Ingredients
Ingredient NameStrength
PETROLATUM (UNII: 4T6H12BN9U)  
LIGHT MINERAL OIL (UNII: N6K5787QVP)  
MINERAL OIL (UNII: T5L8T28FGP)  
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC:70356-125-0128 g in 1 TUBE; Type 0: Not a Combination Product05/01/2016
2NDC:70356-125-0514 g in 1 TUBE; Type 0: Not a Combination Product05/01/2016
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
OTC monograph finalpart333B05/01/2016
Labeler - Sabel Med LLC (091476000)

Revised: 3/2016
Document Id: 2b390b06-cac4-4daa-e054-00144ff8d46c
Set id: 2b390b06-cac3-4daa-e054-00144ff8d46c
Version: 1
Effective Time: 20160331
 
Sabel Med LLC